Investor profile
QUBIS has backed 6 European tech companies across 6 funding rounds between 2018 and 2025, joining rounds totalling €27M. Most active in Healthtech and Software. Data as of 7 Aug 2026.
Also recorded as: QUBIS Limited
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Re-Vana Therapeutics | UK | 1 | €11M |
| CV6 Therapeutics | UK | 1 | €9.4M |
| Sonrai Analytics | Ireland | 1 | €2.4M |
| GenoME Diagnostics | Ireland | 1 | €1.6M |
| AMPLY | Ireland |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Re-Vana Therapeutics | Series A | €11M | 2022-11 |
| CV6 Therapeutics | Other | €9.4M | 2022-11 |
| Sonrai Analytics | Seed | €2.4M | 2022-06 |
| GenoME Diagnostics |
| 1 |
| €1.5M |
| Liopa | UK | 1 | €803k |
| Seed |
| €1.6M |
| 2023-03 |
| AMPLY | Seed | €1.5M | 2025-05 |
| Liopa | Other | €803k | 2018-02 |
